Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2 /neu or EpCAM as target receptorsJan R.H. Hanauer, Michael D. Mühlebach, Lisa Gottschlich et al.|Molecular Therapy — Oncolytics|2016Cited by 22